Aclaris Therapeutics (ACRS) Goodwill & Intangibles (2017 - 2023)

Aclaris Therapeutics' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $751000.0 for Q4 2023.

• In Q4 2023, Goodwill & Intangibles fell 89.82% year-over-year to $751000.0; the TTM figure through Dec 2023 stood at $751000.0 (down 89.82% YoY), while the FY2023 annual figure was $751000.0, down 89.82% from the prior year.
• Goodwill & Intangibles for Q4 2023 stood at $751000.0, down from $7.4 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $92.3 million in Q1 2019, with the low at $751000.0 in Q4 2023.
• The 5-year median for Goodwill & Intangibles is $7.1 million (2020), against an average of $15.2 million.
• The sharpest annual moves came in 2019 and 2020: Goodwill & Intangibles jumped 257.28% in 2019, then slumped 92.0% in 2020.
• Aclaris Therapeutics' Goodwill & Intangibles stood at $25.7 million in 2019, then tumbled by 72.29% to $7.1 million in 2020, then decreased by 1.05% to $7.0 million in 2021, then advanced by 4.71% to $7.4 million in 2022, then tumbled by 89.82% to $751000.0 in 2023.
• Business Quant data shows ACRS's Goodwill & Intangibles at $751000.0 in Q4 2023, $7.4 million in Q3 2023, and $6.9 million in Q2 2023.